Syndax Pharmaceuticals, Inc. Stock Issued During Period, Shares, New Issues
Syndax Pharmaceuticals, Inc. (SNDX) reported Stock Issued During Period, Shares, New Issues of 12.43 million shares for the 1-month period ending 2023-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-02-26
- 2023-12-31: Stock Issued During Period, Shares, New Issues 1 month 12.43M shares.
- 2023-01-24: Stock Issued During Period, Shares, New Issues 86.00K shares.
- 2022-12-31: Stock Issued During Period, Shares, New Issues 1 month 7.84M shares.
- 2021-12-31: Stock Issued During Period, Shares, New Issues 1 month 3.80M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2023-12-31 | 12.43M shares 10-K · filed 2026-02-26 | |
| 2023-01-24 | 86.00K shares 10-K · filed 2026-02-26 | |
| 2022-12-31 | 7.84M shares 10-K · filed 2025-03-03 | |
| 2021-12-31 | 3.80M shares 10-K · filed 2026-02-26 | |
| 2020-06-30 | 2.10M shares 10-Q · filed 2020-11-05 | |
| 2020-05-31 | 6.39M shares 10-Q · filed 2020-11-05 | |
| 2020-03-31 | 2.10M shares 10-Q · filed 2020-05-07 | |
| 2020-01-31 | 3.04M shares 10-Q · filed 2022-11-03 | |
| 2019-03-31 | 2.10M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |